Rankings
▼
Calendar
XNCR FY 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$890M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$126M
+13.7% YoY
Gross Profit
$115M
91.6% margin
Operating Income
-$178M
-141.4% margin
Net Income
-$92M
-73.2% margin
EPS (Diluted)
$-1.24
Cash Flow
Operating Cash Flow
-$135M
Free Cash Flow
-$138M
Stock-Based Comp.
$43M
Balance Sheet
Total Assets
$875M
Total Liabilities
$240M
Stockholders' Equity
$636M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$126M
$110M
+13.7%
Gross Profit
$115M
$110M
+4.1%
Operating Income
-$178M
-$178M
+0.5%
Net Income
-$92M
-$233M
+60.5%
← Q4 2024
All Quarters
Q1 2025 →